Definitive Radiation for Early Stage Lung Cancer: Who is Medically Inoperable?

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 Feb 5

PMID 32016079

Authors

Gonzalo Varela

Nuria M Novoa

Affiliations

Soon will be listed here.

References

Videtic G, Donington J, Giuliani M, Heinzerling J, Karas T, Kelsey C . Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017; 7(5):295-301. DOI: 10.1016/j.prro.2017.04.014. View

Chang J, Senan S, Paul M, Mehran R, Louie A, Balter P . Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015; 16(6):630-7. PMC: 4489408. DOI: 10.1016/S1470-2045(15)70168-3. View

Reshko L, Kalman N, Hugo G, Weiss E . Cardiac radiation dose distribution, cardiac events and mortality in early-stage lung cancer treated with stereotactic body radiation therapy (SBRT). J Thorac Dis. 2018; 10(4):2346-2356. PMC: 5949491. DOI: 10.21037/jtd.2018.04.42. View

Chua G, Lee Min Chua K . Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate. Thorac Cancer. 2019; 10(10):1857-1867. PMC: 6775005. DOI: 10.1111/1759-7714.13160. View

Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, Loi M . Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis. Clin Lung Cancer. 2018; 20(1):e53-e61. DOI: 10.1016/j.cllc.2018.09.003. View

Brunelli A, Varela G, Salati M, Jimenez M, Pompili C, Novoa N . Recalibration of the revised cardiac risk index in lung resection candidates. Ann Thorac Surg. 2010; 90(1):199-203. DOI: 10.1016/j.athoracsur.2010.03.042. View

Brunelli A, Kim A, Berger K, Addrizzo-Harris D . Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):e166S-e190S. DOI: 10.1378/chest.12-2395. View

Nantavithya C, Gomez D, Wei X, Komaki R, Liao Z, Lin S . Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018; 101(3):558-563. DOI: 10.1016/j.ijrobp.2018.02.022. View

Murray L, Ramasamy S, Lilley J, Snee M, Clarke K, Musunuru H . Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort. Clin Oncol (R Coll Radiol). 2015; 28(1):4-12. DOI: 10.1016/j.clon.2015.09.007. View

10.

Haque W, Szeja S, Tann A, Kalra S, Teh B . Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis. Am J Clin Oncol. 2016; 41(3):259-266. DOI: 10.1097/COC.0000000000000265. View

11.

Detillon D, Driessen E, Aarts M, Janssen-Heijnen M, van Eijck C, Veen E . Changes in treatment patterns and survival in elderly patients with stage I non-small-cell lung cancer with the introduction of stereotactic body radiotherapy and video-assisted thoracic surgery. Eur J Cancer. 2018; 101:30-37. DOI: 10.1016/j.ejca.2018.06.016. View

12.

Cao C, Wang D, Chung C, Tian D, Rimner A, Huang J . A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018; 157(1):362-373.e8. PMC: 6582640. DOI: 10.1016/j.jtcvs.2018.08.075. View

13.

Wen S, Han L, Lv H, Xu Y, Li Z, Wang M . A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis. J Invest Surg. 2017; 32(1):27-34. DOI: 10.1080/08941939.2017.1370519. View

14.

Charloux A, Quoix E . Lung segmentectomy: does it offer a real functional benefit over lobectomy?. Eur Respir Rev. 2017; 26(146). PMC: 9488724. DOI: 10.1183/16000617.0079-2017. View

15.

Maebayashi T, Ishibashi N, Aizawa T, Sakaguchi M, Saito T, Kawamori J . Significance of stereotactic body radiotherapy in older patients with early stage non-small cell lung cancer. J Geriatr Oncol. 2018; 9(6):594-599. DOI: 10.1016/j.jgo.2018.03.005. View

16.

Dreyer J, Bremer M, Henkenberens C . Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer. Radiat Oncol. 2018; 13(1):213. PMC: 6215615. DOI: 10.1186/s13014-018-1156-1. View

17.

Kann B, Verma V, Stahl J, Ross R, Dosoretz A, Shafman T . Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma. Radiother Oncol. 2019; 134:44-49. DOI: 10.1016/j.radonc.2019.01.027. View

18.

Berlin E, Buckstein M, Yip R, Yankelevitz D, Rosenzweig K, Henschke C . Definitive Radiation for Stage I Lung Cancer in a Screened Population: Results From the I-ELCAP. Int J Radiat Oncol Biol Phys. 2019; 104(1):122-126. DOI: 10.1016/j.ijrobp.2019.01.069. View

19.

Wong M, McMurry T, Schumacher J, Hu C, Stukenborg G, Francescatti A . Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03). J Oncol Pract. 2018; 14(10):e631-e643. PMC: 6184079. DOI: 10.1200/JOP.18.00175. View

20.

Cassidy R, Patel P, Zhang X, Press R, Switchenko J, Pillai R . Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis. Clin Lung Cancer. 2017; 18(5):551-558.e6. PMC: 5783539. DOI: 10.1016/j.cllc.2017.03.006. View